Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cosmos Health (COSM) Current Deferred Revenue (2018 - 2021)

Cosmos Health (COSM) has disclosed Current Deferred Revenue for 5 consecutive years, with $19378.0 as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, Current Deferred Revenue fell 87.46% year-over-year to $19378.0, compared with a TTM value of $19378.0 through Jun 2021, down 87.46%, and an annual FY2020 reading of $22340.0, down 90.97% over the prior year.
  • Current Deferred Revenue was $19378.0 for Q2 2021 at Cosmos Health, down from $22761.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $1.1 million in Q1 2019 and bottomed at $18752.0 in Q3 2020.
  • Average Current Deferred Revenue over 4 years is $285332.9, with a median of $154567.0 recorded in 2020.
  • Peak annual rise in Current Deferred Revenue hit 59.86% in 2020, while the deepest fall reached 90.97% in 2020.
  • Year by year, Current Deferred Revenue stood at $1.1 million in 2018, then plummeted by 76.83% to $247318.0 in 2019, then plummeted by 90.97% to $22340.0 in 2020, then decreased by 13.26% to $19378.0 in 2021.
  • Business Quant data shows Current Deferred Revenue for COSM at $19378.0 in Q2 2021, $22761.0 in Q1 2021, and $22340.0 in Q4 2020.